2 курс / Гистология / Митрошина_Е_В_Антигипоксическое_и_нейропротекторное_действие_N_

131

70.Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., Mitchell R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors // Mol. Pharmacol. 1995. Vol. 48. Is.3. P.443-450.

71.Fowler C.J., Rojo M.L., Rodriguez-Gaztelumendi A. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity? // Exp Neurol. 2010. Vol. 224, №1. P.37-47.

72.Franklin A., Parmentier-Batteur S., Walter L., Greenberg D.A., Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility // J. Neurosci. 2003. Vol. 27. P. 7767-7775.

73.Gaoni Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish // J. Am. Chem. Soc. 1964. 1964. Vol. 86. P. 1646– 1647.

74.Garq Р., Duncan R.S., Kaja S., Koulen Р. Intracellular Mechanisms of N- Acylethanolamine-Mediated Neuroprotection in a Rat Model of Stroke // Neuroscience. 2010. Vol. 166(1). Р. 252–262.

75.Glaser S.T., Abumrad N.A., Fatade F., Kaczocha M., Studholme K.M., Deutsch D.G. Evidence against the presence of an anandamide transporter // Proc. Natl. Acad. Sci. U S A. 2003. Vol.100. Is.7. P. 4269-4274.

76.Gilbert G.L., Kim H.J., Waataja J.J., Thayer S.A. Delta9tetrahydrocannabinol protects hippocampal neurons from excitotoxicity // Brain Res. 2007 Vol. 1128, №1. P. 61-69.

77.Glass M., Dragunow M. Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist // Neuroreport. 1995. Vol. 6, № 2. P. 241-244.

78.Glass M., Felder C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor // J. Neurosci. 1997. Vol. 17, №14. P.53275333.

79.Glass M., Dragunow M., Faull R.L. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine

132

and GABAA receptor alterations in the human basal ganglia in Huntington's disease // Neuroscience. 2000. Vol. 97. P. 505–519.

80.Gómez-Ruiz M, Hernández M, de Miguel R, Ramos JA. An overview on the biochemistry of the cannabinoid system // Mol Neurobiol. 2007. Vol. 36. Is.1. P.3-14.

81.Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain // Brain Res. 2006. Vol.1071. P.10-23.

82.Gorter, J. A., Petrozzino, J. J., Aronica, E. M., Rosenbaum, D. M., Opitz, T., Bennett, M. V., Connor, J. A. and Zukin, R. S. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil // J. Neurosci. 1997. Vol. 17. P. 6179-6188.

83.Grabiec U., Koch M., Kallendrusch S. Et al. The endocannabinoid N- arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1) // Neuropharm. 2012. Vol. 62. Р. 1797-1807.

84.Gross G.W., Kovalski J.M. Origins of activity patterns in self-orgaizing neuronal networks in vitro // J. Intell. Mater. Syst. Struct. 1999. Vol. 10. P. 558-

85.Ham M.I., Bettencourt L.M., McDaniel F.D., Gross G.W. Spontaneous coordinated activity in cultured networks: analysis of multiple ignition sites, primary circuits, and burst phase delay distributions // Journal of Computational Neuroscience. 2008. Vol. 24, №3. P. 346-357.

86.Harvey B.S., Ohlsson K.S., Mååg J.L., Musgrave I.F., Smid S.D. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro // Neurotoxicology. 2012. Vol. 33. Is.1. P. 138-146.

87.Hashimotodani Y., Ohno-Shosaku T., Kano M. Endocannabinoids and Synaptic Function in the CNS // Neuroscientist 2007. Vol.13 № 2. P. 127–137.

133

88.Hayakawa K, Mishima K, et al. Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism // Neuroreport. 2004. Vol. 15. Р. 2381– 2385.

89.Herkenham M., Lynn A.B., Johnson M.R. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study // J. Neurosci. 1991. Vol. 11. P.563—568.

90.Hodges H., Sowinski P., Fleming P., Kershaw T.R., Sinden J.D., Meldrum B.S., Gray J.A. Contrasting effects of fetal CA1 and CA3 hippocampal grafts on deficits in spatial learning and working memory induced by global cerebral ischaemia in rats // Neuroscience. 1996. Vol.72. P. 959-988.

91.Howlett A. C. Cannabinoid receptor signaling // Handb. Exp. Pharm. 2005.

168р. Р. 53-79.

92.Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R., Pertwee, R.G. // International Union of Pharmacology. XXVII. Classifcation of cannabinoid receptors. Pharmacol. Rev. 2002. Vol. 54. Р. 161-202.

93.Howlett A.C., Breivogel C.S., Childers S.R. et al. Cannabinoid physiology and pharmacology: 30 years of progress // Neuropharmacology. 2004. Vol. 47. Suppl. 1. P.345–358.

94.Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate-cyclase: pharmacology of the response in neuroblastoma cell membranes // Mol. Pharmacol. 1984. Vol. 26. P.532–538.

95.Hu S.S., Bradshaw H.B., Benton V.M., Chen J.S., Huang S.M., Minassi A., Bisogno T., Masuda K., Tan B., Roskoski R. Jr., Cravatt B.F., Di Marzo V., Walker J.M. The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine // Prostaglandins Leukot Essent Fatty Acids. 2009. Vol.81. Is.4. P.291-

96.Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N.,

134

Geppetti P., Walker J.M., Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid receptors // Proc Natl Acad Sci USA. 2002. Vol. 99. P. 8400–8405.

97.Huang S.M., Walker J.M. Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid/endocannabinoid N- arachidonoyldopamine (NADA) // J. Neurophysiol. 2006. Vol. 95: P.1207–1212.

98.Iwabuchi S., Watanabe T., Kawahara K. Spatio-temporal spread of neuronal death after focal photolysis of caged glutamate in neuron/astrocyte co-cultures // Neurochem. Int. 2013. Vol. 62, Is.7. P.1020-1027.

99.Kadhim H.J., Duchateau J., Sébire G. Cytokines and brain injury: invited review // J. Intensive Care Med.2009. Vol. 23. P 236–249.

100.Kahlert S., Zundorf G. and Reiser G. Glutamate-mediated influx of extracellular Ca2+ is coupled with reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes // J. Neurosci. Res. 2005; Vol.79. Р. 262–271.

101.Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission // Physiol Rev. 2009. Vol. 89, №1. Р. 309-80.

102.Kano M. Control of synaptic function by endocannabinoid-mediated retrograde signaling // Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 2014. Vol. 90, Is.7. P.235-50.

103.Karasava Y., Araki H., Otomo S. Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils // Stroke. 1994. Vol. 25, № 3. P. 645-650.

104.Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons // J. Neurosci. 1999. Vol. 19. Р. 4544-4558.

105.Kaur H., Prakash A., Medhi B. Drug therapy in stroke: from preclinical to clinical studies // Pharmacology. 2013. Vol. 92, № 5-6. Р. 324-334.

135

106.Kim D. Y., Kim S. H., Choi H. B., Min C., Gwag B. J. High abundance of GluR1 mRNA and reduced Q/R editing of GluR2 mRNA in individual NADPHdiaphorase neurons // Mol. Cell Neurosci. 2001. Vol. 17. P. 1025-1033.

107.Kim S.H., Won S.J. Mao X.O., Jin K., Greenberg D.A. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury // J. Pharmacol. Exp. Ther. 2005. Vol. 313. P 88–94.

108.Khaspekov L.G., Brenz Verca M.S., Frumkina L.E., Hermann H., Marsicano G., Lutz B. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity // Eur.Neuroci. 2004. Vol. 19, №7. P. 1691-1698.

109.Koch M., Kreutz S., Bottger C., Benz A., Maronde E., Ghadban C., Korf H.W., Dehghani F. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-alpha // Neurotox. Res. 2010. Vol. 19. Р. 330-340.

110.Kofalvi А., Pereira M.F., Rebola N., Rodrigues R.J., OliveiraC.R. and Cunha R.A. Anandamide and NADA bi-directionally modulate presynaptic Ca2 levels and transmitter release in the hippocampus // British Journal of Pharmacology. 2007. Vol. 151. Р.551–563.

111.Koh J. Y., Goldberg M. P., Hartley D. M. and Choi D. W. Non-NMDA receptor-mediated neurotoxicity in cortical culture // J. Neurosci 1990.Vol. 10. P. 693-705.

112.Kreitzer A.C., Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids // J Neurosci. 2001. Vol. 2. Is.20. P.174-176.

113.Kostandy B.B. The role of glutamate in neuronal ischemic injury: the role of spark in fire // Neurol Sci. 2012. Vol.33, №2. P.223-237.

114.Lai T.W., Zhang S., Wang Y.T. Excitotoxicity and stroke: Identifying novel targets for neuroprotection // Prog. Neurobiol. 2013. Vol. 13. P.130-135.

136

115.Lara-Celador I, Goñi-de-Cerio F, Alvarez A, Hilario E. Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxicischemic brain injury // Neural. Regen. Res. 2013. Vol. 8, Is. 8. P.731-744.

116.Leker RR, Gai N, et al. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210 // Stroke. 2003. Vol. 34. №8. Р. 2000– 2006.

117.Lenz R.A., Wagner J.J., Alger B.E. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells // J. Physiol. 1998. Vol. 512. P. 61-73.

118.Li Y., Zhou W., Li X., Zeng S., Liu M., Luo Q. Characterization of synchronized bursts in cultured hippocampal neuronal networks with learning training on microelectrode arrays // Biosens Bioelectron. 2007. Vol. 22, №12. P. 2976-2982.

119.Liu J., Wang L., Harvey-White J. et al. A biosynthetic pathway for anandamide // Proc. Natl. Acad. Sci. U S A. 2006. V. 103. P. 13345–13350.

120.Lozovaya N, Yatsenko N, Beketov A, Tsintsadze T, Burnashev N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids // J. Neurosci. 2005. Vol. 25. Is.33. P.7499-7506.

121.Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, Finazzi-Agrò A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide // J. Biol. Chem. 2000. Vol.275. Is. 18. P.13484-13492.

122.Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system // Handbook of experimental pharmacology. 2005. Vol.

168.P. 299-325.

123.Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor // J. Neurosci. 1995. Vol.15. Is.10. P.6552-6561.

124.Madhavan R., Chao Z.C., Potter S.M. Spontaneous bursts are better indicators of tetanus-induced plasticity than responses to probe stimuli //

137

Proceeding of Second International IEEE EMBS Conference on Neural Engineering. 2006. P. 5-8.

125.Madhavan R, Chao ZC, Potter SM. Plasticity of recurring spatiotemporal activity patterns in cortical networks // Phys Biol. 2007. Vol.4, Is.3. p. 181-93.

126.Maresz K., Carrier E.J., Ponomarev E.D., Hillard C.J., Dittel B.N. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli // J. Neurochem. 2005. Vol.95. Is.2. P.437-445.

127.Maresz K., Pryce G, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on autoreactive T cells // Nat. Med. 2007. Vol .13. №4.492–497.

128.Marinelli S., Di Marzo V., Florenzano F., et al. N-Arachidonoyl-Dopamine Tunes Synaptic Transmission onto Dopaminergic Neurons by Activating both Cannabinoid and Vanilloid Receptors // Neuropsychopharmacology. 2007. Vol. 32, Р. 298–308.

129.Marsicano G., Moosmann B., Hermann H. et al. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1 // J. Neurochem. 2002. Vol. 80, №3. P. 448–456.

130.Massi P., Valenti M., Bolognini D., Parolaro D. Expression and Function of the Endocannabinoid System in Glial Cells // Current Pharmaceutical Design. 2008. Vol. 14. № 23. P 2289-2298.

131.McCollum L., Howlett A.C., Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells // J. Pharmacol. Exp. Ther. 2007. Vol. 321. Is.3. P. 930-937.

132.McFarland M.J., Rakhshan F.R., Wilson J.L., Barker E.L. Endocytic and cellular trafficking processes involved with uptake and metabolism of anandamide // Exp. Biol. (Abstract). 2004. Vol. 397. P. 8.

133.Mechoulam R., Ben-Shabat S., Hanus L. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors // Biochem. Pharmacol. 1995. Vol. 50. P. 83–90.

138

134.Mechoulam R., Panikashvili D and Shohami E. Cannabinoids and brain injury: therapeutic implications // TRENDS in Molecular Medicine. - 2002.Vol.8, №2. P. 58 -61.

135.Mechoulam R., Shohami, E., 2007. Endocannabinoids and traumatic brain injury // Mol. Neurobiol. Vol. 36. Р. 68-74.

136.Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P.L. Excitotoxicity: bridge to v arious triggers in neurodegenerative disorders // Eur. J. Pharmacol. 2013. Vol. 698, №1-3. P. 6-18.

137.Moesgaard B., Hansen H.H., Hansen S.L., Hansen S.H., Petersen G., Hansen H.S. Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure // Lipids. 2003. Vol. 38. Is.4. P. 387-390.

138.Morena M, Campolongo P. The endocannabinoid system: an emotional buffer in the modulation of memory function // Neurobiol Learn Mem. 2014. Vol.

112.P. 30-43.

139.Morgan N.H., Stanford I.M., Woodhall G.L. Functional CB2 type cannabinoid receptors at CNS synapses // Neuropharmacology. 2009. Vol. 57. P. 356–368.

140.Morris R.G.M. Development of a water-maze procedure for studing spatial learning in the rat // Neurosci. Meth. 1984. №11. Р. 47-60.

141.Morris R.G.M., Garrud P., O’Keefe J. Place navigation impaired in rats with hippocampal lesions // Nature. 1982. №297. Р. 681-683.

142.Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids // Nature. 1993. Vol. 365. P.61-65.

143.Murikinati S., Jutler E., Keinert T., Ridder D., Muhammad S., Waibler Z., Ledent C., Zimmer A., Kalinke U., Schwaninger M, Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment // The FASEB Journal. 2010. Vol. 24. Р. 788-798

144.Muthian S, Rademacher DJ, et al. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia // Neuroscience. 2004. Vol .129, №3. Р.743–750.

139

145.Nagakura A., Takagi N., Takeo S. Impairment of cerebral cAMP-mediated signal transduction system and of spatial memory function after microsphere embolism in rats // Neurosci. 2002. Vol. 113, № 3. P. 519-528.

146.Nagayama T., Sinor A.D., et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures // J. Neurosci. 1999. Vol 19, №8. Р. 2987–2995.

147.Netto C.A. et al Effects of fetal hippocampal field grafts on ischemicinduced deficits in spatial navigation in the water maze // Neurosci. 1993. Vol. 54, № 1. P. 69-92.

148.Nimmerjahn A, Kirchhoff F, Kerr JN, Heimchen F. Sulforphodamine 101 as

a specific marker of astroglia in the neocortex in vivo // Nat. methods. 2004. Vol.1. P. 31-37

149.Nunez L., Sanchez A., Fonteris R.I., Garcia-Sancho J. Mechanisms for synchronous calcium oscillations in cultured rat cerebellar neurons // Eur.J. Neurosci. 1996. Vol.8.P. 192-201.

150.Núñez L, Senovilla L, Sanz-Blasco S, Chamero P, Alonso MT, Villalobos C, García-Sancho J. Bioluminescence imaging of mitochondrial Ca2+ dynamics in soma and neurites of individual adult mouse sympathetic neurons // J. Physiol. 2007. Vol. 580. P. 385-395.

151.Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses // J Neurosci. 2002. Vol. 22. Is.10. P. 3864-3872.

152.Okamoto Y., Morishita J., Tsuboi K. et al. Molecular characterization of a phospholipase D generating anandamide and its congeners // J. Biol. Chem. 2004. Vol. 279. P. 5298–5305.

153.O'Sullivan S.E., Kendall D.A., Randall M.D. Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) // Br. J. Pharmacol. 2004. Vol. 141. P. 803–812.

140

154.Palazuelos J., Aguado T., Egia A. et al. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation // FASEB J. 2006. Vol. 20. P. 2405–2407.

155.Panikashvili D, Simeonidou C, Ben-Shabat S, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury // Nature. 2001. Vol. 413. р. 527-531.

156.Panikashvili D., Mecholam R. et al. CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition // J. Cereb. Blood Flow Metab. 2005. Vol.

25.Р. 477–484.

157.Panikashvili D., Shein N.A., Mechoulam R., Trembovler V., Kohen R., Alexandrovich A., Shohami E. The endocannabinoid 2-AG protects the blood–

brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines // Neurobiol. Dis.2006. Vol. 22. P 257–264.

158.Paredes M., Etzler J.C., Watts L.T., Zheng W., Lechleiter J.D. Chemical calcium indicators // Methods. 2008. Vol.46. P. 143-151.

159.Parmentier-Batteur S, Jin K, et al. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice // J. Neurosci. 2002. Vol. 22, №22. Р. 9771– 9775.

160.Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J. Mechanisms of cannabidiol neuroprotection in hypoxicischemic newborn pigs: role of 5HT(1A) and CB2 receptors // Neuropharmacology. 2013. Vol. 71. P. 282-291.

161.Patel N.A., Moldow R.L., Patel J.A., Wu G., Chang S.L. Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain // Brain Res. 1998. Vol.797. Is.2. P. 225-233.

162.Pertwee R.G. Cannabinoid pharmacology: the first 66 years // British Journal of Pharmacology. 2006. Vol. 147. P. S163–S171.